Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CBMG | ENGN | RVNC | ||
Company | Cellular Biomedicine | Engene Holdings Inc | Revance Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 19.74 | 8.99 | 3.69 | ||
High | 19.75 | 9.15 | 4.14 | ||
Low | 19.73 | 7.91 | 3.61 | ||
Last | 19.75 | 8.81 | 4.01 | ||
Change | unch | -0.18 | +0.38 | ||
% Change | unch | -2.00% | +10.32% | ||
Volume | 171,900 | 185,603 | 1,604,626 | ||
20-Day Average Volume | 197,580 | 146,755 | 1,984,771 | ||
Previous Close | 19.75 | 8.99 | 3.63 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 19.27 | 8.89 | 3.08 | ||
20-Day Raw Stochastic | 99.77% | 53.63% | 82.29% | ||
20-Day Relative Strength | 67.50% | 41.10% | 61.74% | ||
Weighted Alpha | +21.75 | -50.29 | -73.78 | ||
Today's Opinion | 100% Buy | N/A | 24% Sell | ||
Previous Opinion | 100% Buy | N/A | 56% Sell | ||
Last Month's Opinion | 8% Sell | N/A | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.10% since 02/11/21 | -2.11% since 07/15/24 | +5.25% since 07/15/24 | ||
Low | 19.68 on 02/12/21 | 7.91 on 07/22/24 | 3.56 on 07/18/24 | ||
High | 19.75 on 02/18/21 | 9.40 on 07/16/24 | 4.38 on 07/17/24 | ||
1-Month | |||||
%Chg | +8.76% since 01/19/21 | -2.11% since 06/21/24 | +50.75% since 06/21/24 | ||
Low | 17.60 on 01/28/21 | 7.61 on 06/25/24 | 2.30 on 06/26/24 | ||
High | 19.75 on 02/18/21 | 9.85 on 07/08/24 | 4.38 on 07/17/24 | ||
3-Month | |||||
%Chg | +7.63% since 11/19/20 | -40.47% since 04/22/24 | +10.16% since 04/22/24 | ||
Low | 17.60 on 01/28/21 | 6.91 on 06/05/24 | 2.30 on 06/26/24 | ||
High | 19.75 on 02/18/21 | 16.62 on 04/29/24 | 4.47 on 05/09/24 | ||
6-Month | |||||
%Chg | +7.57% since 08/19/20 | +17.47% since 01/22/24 | -33.50% since 01/22/24 | ||
Low | 16.98 on 11/06/20 | 6.91 on 06/05/24 | 2.30 on 06/26/24 | ||
High | 19.75 on 02/18/21 | 18.40 on 03/26/24 | 7.56 on 03/01/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 384,691 | 397,052 | 379,672 | ||
Shares Outstanding, K | 19,478 | 44,166 | 104,449 | ||
Annual Sales | 340,000 | 0 | 234,040,000 | ||
Annual Net Income | -49,980,000 | 30,000 | -323,990,000 | ||
Last Quarter Sales | 30,000 | 0 | 51,940,000 | ||
Last Quarter Net Income | -17,040,000 | -14,980,000 | -53,150,000 | ||
60-Month Beta | 1.17 | -0.63 | 0.98 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.38 on 06/14/24 | -0.54 on 05/09/24 | ||
Latest Earnings Date | 02/26/21 | N/A | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | 12/24/14 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |